Select a Sector or Industry
Return on Equity Rankings for Biotechnology Industry
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
| Rank | Symbol | Company |
Return on Equity
|
Pro Rating
|
|---|---|---|---|---|
| 1 | ENMD | EntreMed | 664.2% | Go Pro |
| 2 | EXEL | Exelixis | 510.4% | Go Pro |
| 3 | QCOR | Questcor Pharmaceuticals | 59.89% | Go Pro |
| 4 | NBIX | Neurocrine Biosciences | 54.48% | Go Pro |
| 5 | JAZZ | Jazz Pharmaceuticals | 51.20% | Go Pro |
| 6 | SPPI | Spectrum Pharmaceuticals | 50.98% | Go Pro |
| 7 | BDSI | BioDelivery Sciences International | 46.26% | Go Pro |
| 8 | VRTX | Vertex Pharmaceuticals | 42.52% | Go Pro |
| 9 | SIGA | SIGA Technologies | 39.58% | Go Pro |
| 10 | GILD | Gilead Sciences | 39.49% | Go Pro |
| 11 | IMMU | Immunomedics | 33.26% | Go Pro |
| 12 | MNTA | Momenta Pharmaceuticals | 32.75% | Go Pro |
| 13 | PGNX | Progenics Pharmaceuticals | 30.25% | Go Pro |
| 14 | SHPGY | Shire | 29.07% | Go Pro |
| 15 | CBP | China Botanic Pharmaceutical | 28.54% | Go Pro |
| 16 | OMPI | Obagi Medical Products | 27.93% | Go Pro |
| 17 | BSTC | Biospecifics Technologies | 26.74% | Go Pro |
| 18 | CELG | Celgene Corporation | 25.18% | Go Pro |
| 19 | OSIR | Osiris Therapeutics | 24.03% | Go Pro |
| 20 | ACOR | Acorda Therapeutics | 21.06% | Go Pro |
| 21 | BIIB | Biogen Idec | 20.24% | Go Pro |
| 22 | CRL | Charles River Laboratories International | 18.84% | Go Pro |
| 23 | ALXN | Alexion Pharmaceuticals | 18.44% | Go Pro |
| 24 | AMGN | Amgen | 16.70% | Go Pro |
| 25 | VPHM | ViroPharma | 14.08% | Go Pro |
| 26 | CBM | Cambrex Corporation | 13.13% | Go Pro |
| 27 | SNTS | Santarus | 12.32% | Go Pro |
| 28 | ANIK | Anika Therapeutics | 10.82% | Go Pro |
| 29 | ONXX | ONYX Pharmaceuticals | 9.93% | Go Pro |
| 30 | EBS | Emergent BioSolutions | 9.62% | Go Pro |
| 31 | SSRX | 3SBio | 9.20% | Go Pro |
| 32 | SHP | ShangPharma Corporation | 9.10% | Go Pro |
| 33 | ILMN | Illumina | 8.06% | Go Pro |
| 34 | HSKA | Heska Corporation | 3.78% | Go Pro |
| 35 | VICL | Vical | 2.42% | Go Pro |
| 36 | SVA | Sinovac Biotech | -0.74% | Go Pro |
| 37 | CRIS | Curis | -2.12% | Go Pro |
| 38 | NKBP | China Nuokang Bio - Pharmaceutical | -2.38% | Go Pro |
| 39 | CRTX | Cornerstone Therapeutics | -2.43% | Go Pro |
| 40 | NEPT | Neptune Technologies & Bioresources | -4.97% | Go Pro |
| 41 | QLTI | QLT | -9.45% | Go Pro |
| 42 | BMRN | BioMarin Pharmaceutical | -9.73% | Go Pro |
| 43 | ENZN | Enzon Pharmaceuticals | -9.91% | Go Pro |
| 44 | TRGT | Targacept | -11.34% | Go Pro |
| 45 | NABI | Nabi Biopharmaceuticals | -11.50% | Go Pro |
| 46 | TSPT | Transcept Pharmaceuticals | -11.53% | Go Pro |
| 47 | AMRI | Albany Molecular Research | -15.20% | Go Pro |
| 48 | CDXS | Codexis | -15.58% | Go Pro |
| 49 | AFFY | Affymax | -19.47% | Go Pro |
| 50 | HEB | Hemispherx Biopharma | -21.09% | Go Pro |
